Operating Income (Loss) in USD of TransMedics Group, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TransMedics Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2025.
  • TransMedics Group, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was $23.3M, a 494% increase year-over-year.
  • TransMedics Group, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was $96M, a 205% increase year-over-year.
  • TransMedics Group, Inc. annual Operating Income (Loss) for 2024 was $37.5M.
  • TransMedics Group, Inc. annual Operating Income (Loss) for 2023 was -$28.7M, a 8.62% increase from 2022.
  • TransMedics Group, Inc. annual Operating Income (Loss) for 2022 was -$31.4M, a 20.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

TransMedics Group, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $96M $23.3M +$19.4M +494% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-29
Q2 2025 $76.6M $36.6M +$24.1M +192% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 $52.5M $27.4M +$15M +121% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $37.5M $8.64M +$6.04M +232% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $31.5M $3.92M +$32.3M Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-29
Q2 2024 -$803K $12.5M +$13.4M Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 -$14.2M $12.4M +$14.5M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$28.7M $2.6M +$9.38M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$38.1M -$28.3M -$22.8M -411% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$15.3M -$906K +$8.84M +90.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$24.2M -$2.09M +$7.28M +77.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$31.4M -$6.78M +$4.55M +40.2% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$36M -$5.54M +$6.18M +52.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$42.2M -$9.75M +$123K +1.25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$42.3M -$9.37M -$2.86M -44% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$39.4M -$11.3M -$5.43M -92.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$34M -$11.7M -$7.12M -154% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$26.9M -$9.87M -$2.01M -25.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$24.9M -$6.51M +$1.51M +18.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$26.4M -$5.9M +$2.8M +32.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$29.2M -$4.61M +$2.63M +36.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$31.8M -$7.86M -$156K -2.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$31.7M -$8.02M -$2.06M -34.5% Jan 1, 2020 Mar 31, 2020 10-K 2021-03-11
Q4 2019 -$29.6M -$8.69M -$2.33M -36.7% Sep 29, 2019 Dec 28, 2019 10-K 2021-03-11
Q3 2019 -$27.3M -$7.24M -$3.3M -83.9% Jun 30, 2019 Sep 28, 2019 10-K 2021-03-11
Q2 2019 -$24M -$7.71M -$2.55M -49.4% Mar 31, 2019 Jun 29, 2019 10-K 2021-03-11
Q1 2019 -$21.4M -$5.96M -$1.18M -24.7% Dec 30, 2018 Mar 30, 2019 10-K 2021-03-11
Q4 2018 -$20.2M -$6.36M Sep 30, 2018 Dec 29, 2018 10-K 2020-03-17
Q3 2018 -$3.94M Jul 1, 2018 Sep 29, 2018 10-K 2020-03-17
Q2 2018 -$5.16M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-17
Q1 2018 -$4.78M Dec 31, 2017 Mar 31, 2018 10-K 2020-03-17

TransMedics Group, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $37.5M +$66.2M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$28.7M +$2.71M +8.62% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$31.4M +$7.99M +20.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$39.4M -$13M -49.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$26.4M +$3.22M +10.9% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-11
2019 -$29.6M -$9.37M -46.3% Dec 30, 2018 Dec 28, 2019 10-K 2021-03-11
2018 -$20.2M Dec 31, 2017 Dec 29, 2018 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.